FREUND CORPORATION
Climate Impact & Sustainability Data (2022-03 to 2023-02, 2023-03 to 2024-02, 2025-2027)
Reporting Period: 2022-03 to 2023-02
Environmental Metrics
ESG Focus Areas
- Sustainability
- Diversity & Inclusion (D&I)
- Food safety
- Human rights
Environmental Achievements
- Developed eco-conscious food preservatives
- Initiatives to reduce food loss by extending the best-before period of bread
Social Achievements
- Revised human resources system focusing on employee growth and development
- Introduced Restricted Stock Unit Plan for Executive Directors
- Collaboration with Japan Institute of Baking on bread preservation
- Promotion of Diversity and Inclusion (D&I) activities
Climate Goals & Targets
Environmental Challenges
- Pricing competition
- Raw materials procurement
- Industry trends
- Foreign exchange fluctuations
- Human resources
- Business partner relationships
- Impairment risk for non-current assets
- Client company credibility
- Intellectual property
- Product liability
- Public regulations
- Information leakage
- Natural disasters
- Overseas business operational risks
- COVID-19 related risks
- Supply chain disruptions
- Rising raw material prices
- Labor shortage (especially in the U.S.)
- Prolonged lead times
- Decreased profit margins
Mitigation Strategies
- Strengthening sales capabilities
- Improving structure to respond to client needs
- Global structure improvement
- Expanding into India and Italy
- Establishing a joint venture in China (Shanghai FC Center)
- Strengthening understanding of country/region conditions
- Drafting strategies and monitoring individual transactions
- Risk management system
- Compliance and Risk Management Committee
- Internal Control Committee
- Organizational restructuring (March 1, 2023)
- Establishment of Quality Assurance Division
- Uniforming quality assurance functions
Supply Chain Management
Climate-Related Risks & Opportunities
UN Sustainable Development Goals
- Goal 3: Good Health and Well-being
- Goal 2: Zero Hunger
- Goal 9: Industry, Innovation and Infrastructure
- Goal 12: Responsible Consumption and Production
Initiatives related to food safety, health foods, sustainable products, and reduction of food loss contribute to these goals.
Sustainable Products & Innovation
- Eco-conscious food preservatives
Reporting Period: 2023-03 to 2024-02
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Environment
- Social
- Governance
- Diversity & Inclusion
Environmental Achievements
- Commenced a modal shift in the transportation of pharmaceutical excipients, reducing greenhouse gas emissions by approximately 5.8 tons p.a., or 70%.
Social Achievements
- Launched products conscious of environmental issues; strengthened development of orally disintegrating tablet (ODT) related products for easier drug ingestion; developed industry’s first safe drug ingestion concept involving a new generation tablet printing/inspection machine and specialized inks to prevent medical mistakes; using advanced drug formulation technologies to promote the function of effective food ingredients and enable easier ingestion in health foods; expanding aftersales service to help customers achieve stable operation of their production equipment; improving drivers’ work environments through modal shift.
Governance Achievements
- Reorganized operations according to each business segment; established the Machinery Division; combined excipients and food preservatives development teams into the Development Section; implemented “ONE FREUND” initiative to visualize and share supply chain; strengthened understanding of conditions by country/region, drafting strategies, and monitoring individual transactions for overseas business expansion.
Climate Goals & Targets
Long-term Goals:
- Consolidated net sales of ¥40 billion, operating profit of ¥3.2 billion, and an ROE of at least 10% by FY2033.
Medium-term Goals:
- Consolidated net sales of ¥25 billion and operating profit of ¥1.6 billion by FY2026; invest approximately ¥5 billion in facilities, ¥2.5 billion in R&D, and ¥0.7 billion in human capital during the New Medium-term Management Plan period.
Short-term Goals:
- Construct a new plant for pharmaceutical excipients by 2026
Environmental Challenges
- Supply chain disruptions and raw material price increases (global markets excluding Japan); difficulties in procuring some parts and materials, such as semiconductors, increasing lead time from procurement to shipment; delays in raw material procurement causing problems related to changing suppliers and adjusting production; Japan’s “2024 problem” and a BCP perspective requiring supply chain platform rebuilding.
Mitigation Strategies
- Strategic parts inventory to deliver to customers as planned; optimizing supply chain to reduce costs and maintain quality (food preservatives); constructing a new plant for pharmaceutical excipients by 2026 to improve quality management system and stable product supply; developing an overseas production and supply function; pursuing a modal shift in collaboration with MEDICEO CORPORATION; implementing “ONE FREUND” initiative to visualize and share supply chain.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Optimizing supply chain to reduce costs and maintain quality (food preservatives); rebuilding entire supply chain platform; working to change suppliers and adjust production accordingly.
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Environmentally friendly food preservatives; new spherical granule excipient; direct compression tablet production excipients.
Awards & Recognition
- Not disclosed
Reporting Period: 2025-2027
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Environment
- Social
- Governance
Environmental Achievements
- Lowered greenhouse gas emissions by about 5.8 tons through the development and sale of environmentally responsible food preservatives (Antimold-Mild EF) with a biomass content ratio of over 80%.
- Modal shift for shipments of pharmaceutical excipients.
- Development of machinery and systems that use less labor and help protect the environment.
Social Achievements
- Increased percentage of female managers from 14.7% to at least 20%.
- Increased use of available childcare time off by men from 33% to at least 50%.
- Granting restricted stock to increase employee participation in management.
- Holding monthly "One Freund Meeting" to explain management's stance.
- Implementing health management activities.
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Increase the pace and magnitude of group synergies primarily involving sales, marketing and product strategies
- Expansion of the coverage of business activities to more regions of the world
- Supply a larger volume of products while making more improvements concerning quality, delivery times and cost
- Ensure the trouble-free operation of Freund machinery and be a source of new value and solutions for customers
- Stable supply and increased production of excipients (new factory scheduled for completion in spring 2026)
- Combine drug formulation technologies to cut manufacturing expenses of customers (shorter production time)
- Increase job satisfaction and motivation of employees and cut costs by making production operations more efficient
- Use the Freund Group’s five-region global network to meet the increasingly diverse needs of customers, mainly in the pharmaceutical industries of emerging countries.
- Move faster globally to be a source of solutions concerning batteries and energy
- Further upgrade quality management and maintain a reliable supply of products
- Make manufacturing operations less labor-intensive and more automated
- Reduce time needed to develop drug formulations and make manufacturing operations more efficient
- Lower food loss and protect the global environment
Short-term Goals:
- Not disclosed
Environmental Challenges
- Aggravating global environmental problems
- Diversified work styles and lifestyles
- Human resource management
- Requirements for more rigorous governance and compliance
Mitigation Strategies
- Develop machinery and systems that use less labor and help protect the environment
- Modal shift for shipments of pharmaceutical excipients
- Develop environmentally responsible food preservatives
- Increase hiring of new graduates and people with prior work experience
- Expansion of education and training programs
- Job rotations to give people multitasking skills
- Grant restricted stock (more sense of participation in management)
- Hold One Freund Meeting (every month to explain stance of management)
- Health management activities
- Increase pct. of female managers from the current 14.7% to at least 20%
- Increase use of available child care time off by men from the current 33% to at least 50%
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Antimold-Mild EF
- Tablet Coater "HICOATER HV"
- Tablet Automatic Coating Tool "TACT"
- Titration Image Automation System “HIPPO SCAN”
Awards & Recognition
- Not disclosed